Clinical Trials in Austin

Showing 7281-7300 of 11,561 trials

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

NCT03487588

This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.

Seborrheic Keratosis

Aclaris Therapeutics, Inc.41 participantsStarted Mar 2018

Fort Washington, Pennsylvania, United States • Knoxville, Tennessee, United States • Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

NCT01903993

This multicenter, open-label, randomized study will evaluate the efficacy and safety of Atezolizumab compared with docetaxel in participants with advanced or metastatic non-small cell lung cancer after platinum failure. Participants will be randomized to receive either Atezolizumab 1200 milligram (mg) intravenously every 3 weeks or docetaxel 75 milligram per meter square (mg/m\^2) intravenously every 3 weeks. Treatment with Atezolizumab may be continued as long as participants are experiencing clinical benefit as assessed by the investigator, i.e., in the absence of unacceptable toxicity or symptomatic deterioration attributed to disease progression.

Non-Small Cell Lung Cancer

Hoffmann-La Roche287 participantsStarted Aug 2013

Tucson, Arizona, United States • Hot Springs, Arkansas, United States • Loma Linda, California, United States +62 more locations

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Find Trials by Condition in Austin

A Study in Second Line Metastatic Colorectal Cancer

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A Study in Participants With Moderate to Severe Psoriasis

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study in Advanced Solid Tumors

Study of Ramucirumab in Ovarian Cancer

MRI to Detect Breast Tumors in Women

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients